Heart failure care gets a Check-Up: study tests if sharing guidelines boosts treatment

NCT ID NCT07702760

Not yet recruiting Disease control Sponsor: Jasper Brugts MD PhD Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study looks at whether giving doctors—and sometimes patients—personalized reports on recommended heart failure treatments helps more people get the right medications. It involves adults with heart failure and reduced ejection fraction (HFrEF) in the Netherlands. The goal is to see if this 'mirror information' approach improves how closely care follows established guidelines over one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mirror information reports on guideline-directed medical therapy
What this could lead to: If successful, this approach could help more heart failure patients receive the recommended treatments, potentially reducing hospitalizations and deaths.
What could go wrong: The study is observational and does not test a new drug; improvements in care may be modest or not sustained over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GUIDELINE ADHERENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GUIDELINE ADHERENCE HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.